Vivani Medical Statistics
Share Statistics
Vivani Medical has 59.23M shares outstanding. The number of shares has increased by 7.74% in one year.
| Shares Outstanding | 59.23M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 7.2% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 30.20M |
| Failed to Deliver (FTD) Shares | 238 |
| FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 754.37K, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 754.37K |
| Short % of Shares Out | 1.27% |
| Short % of Float | 2.5% |
| Short Ratio (days to cover) | 12.59 |
Valuation Ratios
The PE ratio is -2.02 and the forward PE ratio is -2.3.
| PE Ratio | -2.02 |
| Forward PE | -2.3 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.5 |
| P/FCF Ratio | -2.11 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vivani Medical Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.
| Current Ratio | 4.03 |
| Quick Ratio | 4.03 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.24% and return on capital (ROIC) is -65.04%.
| Return on Equity (ROE) | -1.24% |
| Return on Assets (ROA) | -0.56% |
| Return on Capital (ROIC) | -65.04% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -712.56K |
| Employee Count | 36 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 17.82% in the last 52 weeks. The beta is 3.52, so Vivani Medical 's price volatility has been higher than the market average.
| Beta | 3.52 |
| 52-Week Price Change | 17.82% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 1.4 |
| Relative Strength Index (RSI) | 41.7 |
| Average Volume (20 Days) | 127.03K |
Income Statement
| Revenue | n/a |
| Gross Profit | -357.00K |
| Operating Income | -26.96M |
| Net Income | -25.65M |
| EBITDA | -26.61M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.5 |
Balance Sheet
The company has 20.65M in cash and 20.70M in debt, giving a net cash position of -42.00K.
| Cash & Cash Equivalents | 20.65M |
| Total Debt | 20.70M |
| Net Cash | -42.00K |
| Retained Earnings | -98.44M |
| Total Assets | 42.90M |
| Working Capital | 15.13M |
Cash Flow
In the last 12 months, operating cash flow was -23.70M and capital expenditures -887.00K, giving a free cash flow of -24.59M.
| Operating Cash Flow | -23.70M |
| Capital Expenditures | -887.00K |
| Free Cash Flow | -24.59M |
| FCF Per Share | -0.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VANI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -42.02% |
| FCF Yield | -34.88% |
Analyst Forecast
The average price target for VANI is $3, which is 152.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 152.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Aug 19, 2022. It was a backward split with a ratio of 1:3.
| Last Split Date | Aug 19, 2022 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -3.37 |
| Piotroski F-Score | 2 |